Molecular characteristics and markers of advanced clear cell renal cell carcinoma: Pitfalls due to intratumoral heterogeneity and identification of genetic alterations associated with metastasis-Reference-Cited by-同舟云学术

Molecular characteristics and markers of advanced clear cell renal cell carcinoma: Pitfalls due to intratumoral heterogeneity and identification of genetic alterations associated with metastasis

Published:2020-07-08 Issue:9 Volume:27 Page:790-797
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Obeng Rebecca C¹,Arnold Rebecca S²³,Ogan Kenneth²³,Master Viraj A²³,Pattaras John G²³,Petros John A¹²³⁴,Osunkoya Adeboye O¹²³⁵

Affiliation:

1. Departments ofDepartment of PathologyEmory University School of MedicineAtlanta Georgia USA

2. Department of Urology Emory University School of MedicineAtlanta Georgia USA

3. Winship Cancer Institute of Emory University AtlantaGeorgiaUSA

4. Departments ofDepartment of UrologyVeterans Affairs Medical CenterDecatur Georgia USA

5. Department of Pathology Veterans Affairs Medical Center Decatur Georgia USA

Funder

Cook Family Foundation

Evans County Cares Foundation

VA Merit

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14302

Reference30 articles.

1. Renal-Cell Carcinoma

2. Tumor Size is Associated With Malignant Potential in Renal Cell Carcinoma Cases

3. Renal-Cell Carcinoma

4. Chemotherapy for advanced renal‐cell carcinoma: 1983–1993;Yagoda A;Semin. Oncol.,1995

5. Prognostic Factors for Survival of Patients with Stage IV Renal Cell Carcinoma

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive analysis of signaling lymphocyte activation molecule family as a prognostic biomarker and correlation with immune infiltration in clear cell renal cell carcinoma;Oncology Letters;2024-06-03

2. A missense SNP in the tumor suppressor SETD2 reduces H3K36me3 and mitotic spindle integrity in Drosophila;GENETICS;2024-01-30

3. The emerging genetic landscape of renal cell carcinoma;Diagnostic Molecular Pathology;2024

4. Construction and validation of an m6A RNA methylation regulator prognostic model for early‑stage clear cell renal cell carcinoma;Oncology Letters;2022-06-10

5. External validation of the REMARCC model for the selection of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma: A multicenter retrospective study;Urologic Oncology: Seminars and Original Investigations;2021-12